Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The dexamethasone suppression test in schizophrenia

K Ismail1, R M Murray, M J Wheeler

  • 1Maudsley Hospital, Department of Psychological Medicine, King's College School of Medicine and Dentistry, London.

Psychological Medicine
|May 8, 1998
PubMed
Summary

In schizophrenia patients, dexamethasone suppression test (DST) non-suppression rates were unexpectedly low, despite high depression rates. This suggests a distinct neuroendocrine profile in schizophrenia-related depression compared to major depressive disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are behavioural and inflammatory profiles different according to type of stressor, developmental stage, and sex in rodent models of depression? A systematic review.

Molecular psychiatry·2025
Same author

Measuring refugees' capabilities: translation, adaptation, and valuation of the OxCAP-MH into Juba Arabic for use among South Sudanese male refugees in Uganda.

Journal of patient-reported outcomes·2024
Same author

Medical Termination of Pregnancy - An Emerging Risk for Maternal Mortality.

Irish medical journal·2024
Same author

The molecular and genetic basis of pollen-pistil interactions.

The New phytologist·2021
Same author

Systematic review and meta-analysis of randomized controlled trials of psychological interventions to improve glycaemic control in children and adults with type 1 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2020
Same author

Multidisciplinary healthcare teams' challenges and strategies in supporting people with type 1 diabetes to recover from disordered eating.

Diabetic medicine : a journal of the British Diabetic Association·2019

Area of Science:

  • Neuroendocrinology
  • Psychiatry

Background:

  • Cortisol non-suppression in schizophrenia varies and may link to depression or negative symptoms.
  • The dexamethasone suppression test (DST) is used to assess cortisol regulation.

Purpose of the Study:

  • To investigate cortisol non-suppression rates using the DST in patients with schizophrenia.
  • To explore the relationship between depression, negative symptoms, and cortisol levels in schizophrenia.

Main Methods:

  • Administered DST to 64 patients diagnosed with DSM-IV schizophrenia.
  • Screened for major depression and rated depression (HRSD), negative symptoms (SANS), and overall psychopathology (BPRS).
  • Measured post-dexamethasone cortisol levels and analyzed correlations with clinical ratings.

Related Experiment Videos

Main Results:

  • 36% of patients met criteria for major depression; 42% had a history of parasuicide.
  • Only one patient showed cortisol non-suppression (post-dexamethasone level > 138 nmol/l).
  • Cortisol levels correlated with depression (HRSD) and general psychopathology (BPRS) scores, but not negative symptoms (SANS).

Conclusions:

  • Schizophrenia patients exhibited very low rates of dexamethasone non-suppression.
  • High rates of depression in this cohort suggest a potentially different neuroendocrine profile compared to major depressive disorders.
  • Accurate measurement of dexamethasone levels is crucial for reliable DST interpretation.